In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Natera, Inc.. Trade Record

NASDAQ:NTRA Natera, Inc. stock gains 21.78% Exit May 19, 2017 a Trade Record by priceseries

Trade Chart
Trade Chart NTRA Apr 24, 2017, priceSeries
About Natera, Inc.

Natera, Inc., a diagnostics company, provides preconception and prenatal genetic testing services. It primarily offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus typically with a blood draw from the mother; Horizon carrier screening to determine carrier status for various genetic diseases that could be passed on to the carrier's children; and Spectrum pre-implantation genetic screening and Spectrum pre-implantation genetic diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides products of conception testing under the Anora brand to analyze fetal chromosomes to understand the cause of miscarriage; non-invasive paternity testing products to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father. In addition, it offers Constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests. The company offers products through its direct sales force, as well as through a network of approximately 70 laboratory and distribution partners in the United States and internationally. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.

Trade Information
Trade Type
LONG
ReliabilityScore™
91.67
Entry Date
Apr 24, 2017
Entry Price
8.36
Sell Date
May 19, 2017
Sell Price
10.18
Net Gain
21.78%
Hold Time
19 Trading Days